PT
Prana Therapies, Inc.
SEC filingBiotechnology · Encinitas, CA
Amount raised$40.2Msold at filing
Total offering$40.2M
Investors in the raise9count reported to the SEC
FiledAug 10, 2026first sale Nov 25, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ben AuspitzDirector
Sheila Gujrathi, M.D.Executive Officer, Director
Hector OrtegaExecutive Officer
Ryan SullivanExecutive Officer
Alexis BorisyDirector
Executive officers, directors and promoters as listed on the Form D.